Business Update

Distribution agreement dispute resolved for OraQuick Rapid HIV-1 Antibody Test

Published in AIDS Weekly, March 22nd, 2004

OraSure Technologies, Inc., (OSUR) announced the receipt of an arbitrator's decision resolving its dispute with Abbott Laboratories under the parties' distribution agreement for the company's OraQuick Rapid HIV-1 Antibody Test.

The arbitrator ruled that the agreement was not terminated and will remain in effect. In addition, consistent with the arbitrator's rulings OraSure has notified Abbott that the agreement has been converted from co-exclusive to a non-exclusive distribution arrangement.

Pursuant to the terms of the agreement, the arbitrator's determination is final and may not be appealed by either party.

"We are pleased that...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2004-03-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry